Medical Weight Loss for Bethlehem, Pennsylvania Residents
Bethlehem, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Bethlehem through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Bethlehem Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Bethlehem, Pennsylvania residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
From our Costa Mesa, California practice, we provide Bethlehem with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
Bethlehem is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout Downtown, the SouthSide, and the greater Lehigh Valley. Compounded semaglutide and tirzepatide ship directly to your door in Pennsylvania, and a licensed physician reviews every plan before anything is prescribed.
Like much of Pennsylvania, many people in Bethlehem want a physician-supervised weight-loss option without local waitlists or unclear pricing. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Bethlehem patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Bethlehem
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Bethlehem address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Bethlehem
Does New Hope Weight Loss treat patients in Bethlehem?
Yes. Although the clinic is in Costa Mesa, California, we treat Bethlehem, Pennsylvania residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Bethlehem?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Bethlehem address in cold-pack packaging.
What do Bethlehem patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Bethlehem do you serve?
We serve patients from across Bethlehem by telehealth, including Downtown, the SouthSide, and the greater Lehigh Valley.
What support is there for side effects for Bethlehem patients?
Dr. Sharma starts Bethlehem patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bethlehem, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.